BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27288764)

  • 1. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
    Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
    J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.
    Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
    Tomography; 2016 Mar; 2(1):56-66. PubMed ID: 27200418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
    Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
    Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.
    Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Kinahan PE; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
    Tomography; 2019 Mar; 5(1):99-109. PubMed ID: 30854447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic analysis of prostate cancer using independent component analysis.
    Mehrabian H; Da Rosa M; Haider MA; Martel AL
    Magn Reson Imaging; 2015 Dec; 33(10):1236-1245. PubMed ID: 26297961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatability of arterial input functions and kinetic parameters in muscle obtained by dynamic contrast enhanced MR imaging of the head and neck.
    Koopman T; Martens RM; Lavini C; Yaqub M; Castelijns JA; Boellaard R; Marcus JT
    Magn Reson Imaging; 2020 May; 68():1-8. PubMed ID: 31978517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
    Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
    Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
    Ziayee F; Müller-Lutz A; Gross J; Quentin M; Ullrich T; Heusch P; Arsov C; Rabenalt R; Albers P; Antoch G; Wittsack HJ; Schimmöller L
    Magn Reson Imaging; 2018 Nov; 53():28-33. PubMed ID: 29902565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
    Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
    Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Different Measurement Methods of Arterial Input Function on Quantitative Dynamic Contrast-Enhanced MRI Parameters in Head and Neck Cancer.
    Dong W; Volk A; Djaroum M; Girot C; Balleyguier C; Lebon V; Garcia G; Ammari S; Temam S; Gorphe P; Wei L; Pitre-Champagnat S; Lassau N; Bidault F
    J Magn Reson Imaging; 2023 Jul; 58(1):122-132. PubMed ID: 36269053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Orthotopic Mouse Model of Pancreatic Cancer.
    Cao J; Pickup S; Rosen M; Zhou R
    Mol Imaging Biol; 2023 Aug; 25(4):638-647. PubMed ID: 37166575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blind deconvolution estimation of an arterial input function for small animal DCE-MRI.
    Jiřík R; Taxt T; Macíček O; Bartoš M; Kratochvíla J; Souček K; Dražanová E; Krátká L; Hampl A; Starčuk Z
    Magn Reson Imaging; 2019 Oct; 62():46-56. PubMed ID: 31150814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCE-MRI protocol for constraining absolute pharmacokinetic modeling errors within specific accuracy limits.
    Knight SP; Meaney JF; Fagan AJ
    Med Phys; 2019 Aug; 46(8):3592-3602. PubMed ID: 31148187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.
    Rata M; Collins DJ; Darcy J; Messiou C; Tunariu N; Desouza N; Young H; Leach MO; Orton MR
    Eur Radiol; 2016 Jul; 26(7):1991-8. PubMed ID: 26385804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.
    Klawer EME; van Houdt PJ; Pos FJ; Heijmink SWTPJ; van Osch MJP; van der Heide UA
    NMR Biomed; 2018 Sep; 31(9):e3946. PubMed ID: 29974981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
    Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MRI parametric mapping using high spatiotemporal resolution Golden-angle RAdial Sparse Parallel MRI and iterative joint estimation of the arterial input function and pharmacokinetic parameters.
    Mazaheri Y; Kim N; Lakhman Y; Jafari R; Vargas A; Otazo R
    NMR Biomed; 2022 Jul; 35(7):e4718. PubMed ID: 35226774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different population-averaged arterial-input-functions in dynamic contrast-enhanced MRI of the prostate: Effects on pharmacokinetic parameters and their diagnostic performance.
    Othman AE; Falkner F; Kessler DE; Martirosian P; Weiss J; Kruck S; Kaufmann S; Grimm R; Kramer U; Nikolaou K; Notohamiprodjo M
    Magn Reson Imaging; 2016 May; 34(4):496-501. PubMed ID: 26708031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The arterial input function: Spatial dependence within the imaging volume and its influence on 3D quantitative dynamic contrast-enhanced MRI for head and neck cancer.
    Roberts J; Kim SE; Kholmovski EG; Hitchcock Y; Richards TJ; Anzai Y
    Magn Reson Imaging; 2023 Sep; 101():40-46. PubMed ID: 37030177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.